Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canine Baculoviral IAP repeat containing 5 (BIRC5) ELISA Kit-Sandwich

Name: Canine Baculoviral IAP repeat containing 5 (BIRC5) ELISA Kit-Sandwich
SKU: EK10F910
Rating: 5 (1 reviews)

Cat. No.EK10F910

Product TypeAnimal Immunoassay Kits

Size

Inquiry Now Add to Inquiry List

Product Overview

BioVenic Canine BIRC5 ELISA Kit-Sandwich is designed for the quantitative determination of Canine BIRC5 in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich

Specificity The assay kit is specific for Canine BIRC5.

Target Species Canine

Species Reactivity Canine

Detection Range 62.5-4000 pg/mL

Sensitivity 12.5 pg/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 180 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

Baculoviral IAP repeat containing 5 is encoded by the BIRC5 gene in dogs. In a previous research, survivin/BIRC5 showed as well-promising results as a prognostic marker in canine melanoma.

Target/Biomarker Canine BIRC5

Target Synonym baculoviral IAP repeat containing 5; baculoviral IAP repeat-containing protein 5; apoptosis inhibitor survivin; survivin

Gene ID 442936

UniProt ID Q8I009

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Bongiovanni, L. et al. H2AFZ: a novel prognostic marker in canine melanoma and a predictive marker for resistance to CDK4/6 inhibitor treatment. Frontiers in Veterinary Science. 2021, 8: 705359.